nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Injury—Prednisone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Linezolid—Vaginal infection—Methotrexate—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Linezolid—Pancreatitis—Triamcinolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Linezolid—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Linezolid—Sweating increased—Triamcinolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Linezolid—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Linezolid—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Linezolid—Hypokalaemia—Betamethasone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Linezolid—Ecchymosis—Methotrexate—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Linezolid—Urine output increased—Methotrexate—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Linezolid—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Linezolid—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Linezolid—Sepsis—Methotrexate—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Linezolid—Sweating increased—Dexamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Linezolid—Sweating increased—Betamethasone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Linezolid—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Linezolid—Haemoglobin—Prednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Linezolid—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Linezolid—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Linezolid—Haemorrhage—Prednisolone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Linezolid—Polyuria—Methotrexate—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Linezolid—Hypokalaemia—Prednisone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Linezolid—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Linezolid—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Linezolid—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Linezolid—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Linezolid—Haemorrhage—Triamcinolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Linezolid—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Linezolid—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Linezolid—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Linezolid—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Linezolid—Pancreatitis—Prednisone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Linezolid—Sweating increased—Prednisone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Linezolid—Erythema—Prednisolone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Linezolid—Neutropenia—Prednisone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Linezolid—Haemoglobin—Betamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Linezolid—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Linezolid—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Linezolid—Haemorrhage—Betamethasone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Linezolid—Vision blurred—Prednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Linezolid—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Linezolid—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Linezolid—Erythema—Triamcinolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Linezolid—Erythema—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Linezolid—Angioedema—Prednisolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Linezolid—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Linezolid—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Linezolid—Vertigo—Prednisolone—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Linezolid—Convulsion—Prednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Linezolid—Hypertension—Prednisolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Linezolid—Eosinophilia—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Linezolid—Pancreatitis—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Linezolid—Angioedema—Triamcinolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Linezolid—Haemoglobin—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Linezolid—Angioedema—Methylprednisolone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Linezolid—Haemorrhage—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Linezolid—Erythema—Dexamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Linezolid—Erythema—Betamethasone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Linezolid—Pancytopenia—Methotrexate—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Linezolid—Vertigo—Triamcinolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Linezolid—Vertigo—Methylprednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Linezolid—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Linezolid—Neutropenia—Methotrexate—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Linezolid—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Linezolid—Cough—Triamcinolone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Linezolid—Convulsion—Triamcinolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Linezolid—Convulsion—Methylprednisolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Linezolid—Hypertension—Triamcinolone—psoriatic arthritis	0.00188	0.00188	CcSEcCtD
Linezolid—Hypertension—Methylprednisolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Linezolid—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Linezolid—Pneumonia—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Linezolid—Dry mouth—Triamcinolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Linezolid—Renal failure—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Linezolid—Angioedema—Dexamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Linezolid—Angioedema—Betamethasone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Linezolid—Stomatitis—Methotrexate—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Linezolid—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Linezolid—Vertigo—Dexamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Linezolid—Vertigo—Betamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Linezolid—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Linezolid—Insomnia—Prednisolone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Linezolid—Paraesthesia—Prednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Linezolid—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Linezolid—Erythema—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Linezolid—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Linezolid—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Linezolid—Convulsion—Dexamethasone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Linezolid—Convulsion—Betamethasone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Linezolid—Hypertension—Dexamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Linezolid—Hypertension—Betamethasone—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Linezolid—Haemoglobin—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Linezolid—Pain—Prednisolone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Linezolid—Haemorrhage—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Linezolid—Pharyngitis—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Linezolid—Vision blurred—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Linezolid—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Linezolid—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Linezolid—Insomnia—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Linezolid—Insomnia—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Linezolid—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Linezolid—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Linezolid—Anaemia—Prednisone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Linezolid—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Linezolid—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Linezolid—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Linezolid—Angioedema—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Linezolid—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Linezolid—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Linezolid—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Linezolid—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Linezolid—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Linezolid—Vertigo—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Linezolid—Tinnitus—Methotrexate—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Linezolid—Anorexia—Dexamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Linezolid—Anorexia—Betamethasone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Linezolid—Urticaria—Prednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Linezolid—Fatigue—Triamcinolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Linezolid—Fatigue—Methylprednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Linezolid—Pain—Triamcinolone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Linezolid—Convulsion—Prednisone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Linezolid—Hypertension—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Linezolid—Chills—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Linezolid—Insomnia—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Linezolid—Insomnia—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Linezolid—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Linezolid—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Linezolid—Paraesthesia—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Linezolid—Erythema—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Linezolid—Dyspepsia—Betamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Linezolid—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Linezolid—Urticaria—Triamcinolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Linezolid—Urticaria—Methylprednisolone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Linezolid—Dysgeusia—Methotrexate—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Linezolid—Body temperature increased—Triamcinolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Linezolid—Anaphylactic shock—Prednisone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Linezolid—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Linezolid—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Linezolid—Decreased appetite—Betamethasone—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Linezolid—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Linezolid—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Linezolid—Fatigue—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Linezolid—Fatigue—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Linezolid—Pain—Dexamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Linezolid—Pain—Betamethasone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Linezolid—Skin disorder—Prednisone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Linezolid—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Linezolid—Vision blurred—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Linezolid—Anorexia—Prednisone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Linezolid—Anaemia—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Linezolid—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Linezolid—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Linezolid—Vertigo—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Linezolid—Leukopenia—Methotrexate—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Linezolid—Urticaria—Betamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Linezolid—Urticaria—Dexamethasone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Linezolid—Dizziness—Prednisolone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Linezolid—Asthenia—Triamcinolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Body temperature increased—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Abdominal pain—Betamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Asthenia—Methylprednisolone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Insomnia—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Linezolid—Paraesthesia—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Linezolid—Pruritus—Triamcinolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Linezolid—Cough—Methotrexate—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Linezolid—Pruritus—Methylprednisolone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Linezolid—Convulsion—Methotrexate—psoriatic arthritis	0.00124	0.00124	CcSEcCtD
Linezolid—Dyspepsia—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Linezolid—Decreased appetite—Prednisone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Linezolid—Rash—Prednisolone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Linezolid—Dermatitis—Prednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Linezolid—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Linezolid—Fatigue—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Linezolid—Headache—Prednisolone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Linezolid—Constipation—Prednisone—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Linezolid—Dizziness—Triamcinolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Linezolid—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Linezolid—Dizziness—Methylprednisolone—psoriatic arthritis	0.00117	0.00117	CcSEcCtD
Linezolid—Asthenia—Betamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Linezolid—Asthenia—Dexamethasone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Linezolid—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Linezolid—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Linezolid—Nausea—Prednisolone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Linezolid—Pruritus—Dexamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Linezolid—Pruritus—Betamethasone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Linezolid—Skin disorder—Methotrexate—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Linezolid—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Linezolid—Vomiting—Triamcinolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Linezolid—Vomiting—Methylprednisolone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Linezolid—Rash—Triamcinolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Linezolid—Dermatitis—Triamcinolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Linezolid—Anorexia—Methotrexate—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Linezolid—Rash—Methylprednisolone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Linezolid—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Linezolid—Urticaria—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Linezolid—Headache—Triamcinolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Linezolid—Headache—Methylprednisolone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Linezolid—Abdominal pain—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Linezolid—Body temperature increased—Prednisone—psoriatic arthritis	0.00111	0.00111	CcSEcCtD
Linezolid—Diarrhoea—Dexamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Linezolid—Diarrhoea—Betamethasone—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Linezolid—Dizziness—Dexamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Linezolid—Dizziness—Betamethasone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Linezolid—Insomnia—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Linezolid—Nausea—Triamcinolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Linezolid—Paraesthesia—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Linezolid—Nausea—Methylprednisolone—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Linezolid—Dyspnoea—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Linezolid—Somnolence—Methotrexate—psoriatic arthritis	0.00104	0.00104	CcSEcCtD
Linezolid—Dyspepsia—Methotrexate—psoriatic arthritis	0.00103	0.00103	CcSEcCtD
Linezolid—Vomiting—Dexamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Linezolid—Vomiting—Betamethasone—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Linezolid—Decreased appetite—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Linezolid—Rash—Dexamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Rash—Betamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Dermatitis—Dexamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Dermatitis—Betamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Fatigue—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Headache—Dexamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Headache—Betamethasone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Asthenia—Prednisone—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Linezolid—Pain—Methotrexate—psoriatic arthritis	0.001	0.001	CcSEcCtD
Linezolid—Pruritus—Prednisone—psoriatic arthritis	0.000992	0.000992	CcSEcCtD
Linezolid—Diarrhoea—Prednisone—psoriatic arthritis	0.000959	0.000959	CcSEcCtD
Linezolid—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000958	0.000958	CcSEcCtD
Linezolid—Nausea—Dexamethasone—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Linezolid—Nausea—Betamethasone—psoriatic arthritis	0.000956	0.000956	CcSEcCtD
Linezolid—Urticaria—Methotrexate—psoriatic arthritis	0.00093	0.00093	CcSEcCtD
Linezolid—Dizziness—Prednisone—psoriatic arthritis	0.000927	0.000927	CcSEcCtD
Linezolid—Abdominal pain—Methotrexate—psoriatic arthritis	0.000926	0.000926	CcSEcCtD
Linezolid—Body temperature increased—Methotrexate—psoriatic arthritis	0.000926	0.000926	CcSEcCtD
Linezolid—Vomiting—Prednisone—psoriatic arthritis	0.000891	0.000891	CcSEcCtD
Linezolid—Rash—Prednisone—psoriatic arthritis	0.000884	0.000884	CcSEcCtD
Linezolid—Dermatitis—Prednisone—psoriatic arthritis	0.000883	0.000883	CcSEcCtD
Linezolid—Headache—Prednisone—psoriatic arthritis	0.000878	0.000878	CcSEcCtD
Linezolid—Asthenia—Methotrexate—psoriatic arthritis	0.00084	0.00084	CcSEcCtD
Linezolid—Nausea—Prednisone—psoriatic arthritis	0.000832	0.000832	CcSEcCtD
Linezolid—Pruritus—Methotrexate—psoriatic arthritis	0.000829	0.000829	CcSEcCtD
Linezolid—Diarrhoea—Methotrexate—psoriatic arthritis	0.000801	0.000801	CcSEcCtD
Linezolid—Dizziness—Methotrexate—psoriatic arthritis	0.000775	0.000775	CcSEcCtD
Linezolid—Vomiting—Methotrexate—psoriatic arthritis	0.000745	0.000745	CcSEcCtD
Linezolid—Rash—Methotrexate—psoriatic arthritis	0.000738	0.000738	CcSEcCtD
Linezolid—Dermatitis—Methotrexate—psoriatic arthritis	0.000738	0.000738	CcSEcCtD
Linezolid—Headache—Methotrexate—psoriatic arthritis	0.000734	0.000734	CcSEcCtD
Linezolid—Nausea—Methotrexate—psoriatic arthritis	0.000696	0.000696	CcSEcCtD
